Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
The push is on to determine if the copious dollars expended to fund CME programs nationally actually translate to better patient care. The buzz phrase in the CME world these days is “outcomes measurement,” i.e., the role continuing medical...
When one of her pharma clients was launching a new injectable drug to help stimulate white blood cells to fight infection in chemotherapy patients, Clare O'Boyle, director of entertainment, United States, for Jack Morton Worldwide, New York, chose...
The Permanente Medical Group of the Kaiser Permanente health plan organization, which operates in nine states and Washington, D.C., recently updated its conflict-of-interest policy for its more than 5,000 Northern California physicians to make it...
CME IS ON THE FEDERAL radar screen once again. This time the U.S. Senate is investigating pharma companies' educational grants, including funding for CME. In June, Sens. Chuck Grassley (R-Iowa) and Max Baucus (D-Montana) sent letters to...
The American Academy of Family Physicians, Leawood, Kan., did something a little different this year with its eight-year-old Annual Clinical Focus educational initiative — it was done entirely through video-streaming on the Web. In previous years...
WHILE THERE IS nothing inherently wrong in developing CME activities supported by one company — and this funding model should and will continue — CME support by several companies elevates standards of independence, objectivity, and balance to a...
I DIDN'T KNOW WHETHER to laugh, cry, or bang my head against the wall after most of the interviews I did for this issue's cover story (see page 38). Are we really looking at just a few bad apples, or has the whole barrel gone rotten on us when it...
Most would agree that the trend toward evidence-based medicine, and toward evidence-based continuing medical education, is a good one, that doctors should be basing their treatment decisions on the best available data, rather than anecdotal...
IT WAS WITH a growing sense of apprehension that I read the letter sent in June from the U.S. Senate finance committee to pharmaceutical companies asking them to explain their process for awarding educational grants. The senators want to make sure...
Medical Meetings is looking to develop a one-stop shop of resources that readers can use, free of charge, as templates to develop their own forms, letters, and policies. Do you have sample speaker invitation letters, new ACCME Standards conflict...
